Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Japanese Journal of Clinical Oncology|April 7, 2016
Urologic cancer in ChinaCheng Pang, Youyan Guan, Hongbo Li, et al.Pharmaceutics|April 28, 2023
Research Advances in Nucleic Acid Delivery System for Rheumatoid Arthritis TherapyXintong Zhang, Yanhong Liu, Congcong Xiao, et al.Oncology Letters|May 20, 2017
Reninoma coexisting with adrenal adenoma during pregnancy: A case reportMei Xue, Yan Chen, Jin Zhang, et al.Clinical Genitourinary Cancer|August 17, 2025
Expression and Prognostic Significance of Different Antibody-Drug Conjugate Target Proteins in Urachal CarcinomaTian Han, Honglei Cui, Gan Du, et al.Journal of Oncology|July 11, 2022
Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell CarcinomaRuiyang Xie, Jie Wu, Bingqing Shang, et al.Cancer Innovation|December 13, 2023
Deaths and adverse events from adjuvant therapy with immune checkpoint inhibitors in solid malignant tumors: A systematic review and network meta-analysisRuiyang Xie, Jie Wu, Bingqing Shang, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 21, 2020
Enhancing anti-melanoma outcomes in mice using novel chitooligosaccharide nanoparticles loaded with therapeutic survivin-targeted siRNAXuan Liu, Liqing Chen, Yingying Zhang, et al.Urologic Oncology|February 13, 2025
Safety and efficacy of intravesical Bacillus Calmette-Guerin instillation for superficial recurrence following bladder-sparing therapy of muscle invasive bladder cancer: A retrospective studyGan Du, Youyan Guan, Ruiyang Xie, et al.International Journal of Pharmaceutics|July 2, 2019
Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneolLingwei Meng, Xiaoyang Chu, Haoyue Xing, et al.Journal of Nanobiotechnology|March 10, 2025
Co-delivery of axitinib and PD-L1 siRNA for the synergism of vascular normalization and immune checkpoint inhibition to boost anticancer immunityYanhong Liu, Liming Gong, Jing Feng, et al.Pageof 2